ORIGINAL ARTICLE

Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases

M Koda, M Sulkowska, L Kanczuga-Koda and S Sulkowski

Department of Clinical Pathology, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland

Correspondence to:
Correspondence to:
Professor S Sulkowski
Department of Clinical Pathology, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland; sulek{at}zeus.amb.edu.pl

Background: Insulin receptor substrate 1 (IRS-1) transmits signals from the insulin-like growth factor I receptor (IGF-IR) and insulin receptor (IR) and has been associated with the pathogenesis of cancer. IRS-1 downregulation has been suggested to play a role in breast cancer progression, but no simultaneous assessments of IRS-1 expression in primary breast cancer and metastases have been performed.

Aims: To assess IRS-1 expression in primary and metastatic breast cancer.

Methods: IRS-1 expression was analysed by means of immunohistochemistry in 109 samples of primary breast cancer and in 42 matched primary and metastatic tumours. In addition, IRS-1 expression was correlated with selected clinicopathological features, including oestrogen receptor (ER) and proliferation marker Ki-67 status.

Results: Positive cytoplasmic IRS-1 immunostaining was found in 69.7% (76 of 109) and 76.2% (32 of 42) of the primary and metastatic tumours, respectively. Both IRS-1 positive and IRS-1 negative primary tumours produced IRS-1 positive and IRS-1 negative metastases. IRS-1 expression in primary tumours correlated with poorly differentiated (G3) breast cancer (p<0.005) and with lymph node involvement (p<0.05). In the subgroup of ER positive primary tumours, IRS-1 expression positively correlated with Ki-67 (p<0.02, r = 0.351), but in the subgroup of ER negative primary tumours there was a negative correlation (p<0.03, r = –0.509). IRS-1 expression in lymph node metastases correlated with neither ER nor Ki-67.

Conclusions: IRS-1 might be involved in breast cancer progression. Knowledge about differences between primary and metastatic tumours might help to understand mechanisms of breast cancer progression and lead to the development of more effective anticancer drugs.

Abbreviations: E2, 17ß-oestradiol; ER, oestrogen receptor ; IGF-I, insulin-like growth factor I; IGF-IR, insulin-like growth factor I receptor; IR, insulin receptor; IRS-1, insulin receptor substrate 1

Keywords: breast cancer; lymph node metastases; insulin receptor substrate-1; oestrogen receptor ; proliferation

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ramocki, N. M., Wilkins, H. R., Magness, S. T., Simmons, J. G., Scull, B. P., Lee, G. H., McNaughton, K. K., Lund, P. K. (2008). Insulin Receptor Substrate-1 Deficiency Promotes Apoptosis in the Putative Intestinal Crypt Stem Cell Region, Limits Apcmin/+ Tumors, and Regulates Sox9. Endocrinology 149: 261-267 [Abstract] [Full Text]  
• Ravikumar, S., Perez-Liz, G., Del Vale, L., Soprano, D. R., Soprano, K. J. (2007). Insulin Receptor Substrate-1 Is an Important Mediator of Ovarian Cancer Cell Growth Suppression by All-trans Retinoic Acid. Cancer Res. 67: 9266-9275 [Abstract] [Full Text]  
• Sisci, D., Morelli, C., Garofalo, C., Romeo, F., Morabito, L., Casaburi, F., Middea, E., Cascio, S., Brunelli, E., Ando, S., Surmacz, E. (2007). Expression of nuclear insulin receptor substrate 1 in breast cancer. J. Clin. Pathol. 60: 633-641 [Abstract] [Full Text]  
• Liu, T.-J., LaFortune, T., Honda, T., Ohmori, O., Hatakeyama, S., Meyer, T., Jackson, D., de Groot, J., Yung, W.K. A. (2007). Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Molecular Cancer Therapeutics 6: 1357-1367 [Abstract] [Full Text]  
• Dearth, R. K., Cui, X., Kim, H.-J., Kuiatse, I., Lawrence, N. A., Zhang, X., Divisova, J., Britton, O. L., Mohsin, S., Allred, D. C., Hadsell, D. L., Lee, A. V. (2006). Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2. Mol. Cell. Biol. 26: 9302-9314 [Abstract] [Full Text]  
• Ma, Z., Gibson, S. L., Byrne, M. A., Zhang, J., White, M. F., Shaw, L. M. (2006). Suppression of Insulin Receptor Substrate 1 (IRS-1) Promotes Mammary Tumor Metastasis. Mol. Cell. Biol. 26: 9338-9351 [Abstract] [Full Text]